NYSE · Healthcare · Healthcare Plans · USA
Elevance Health Inc is a large cap company (market value between $10 billion and $200 billion) in the Healthcare Plans industry.
Elevance Health is a health insurance company serving members through affiliated health plans in individual, employer group, Medicaid and Medicare markets. The company offers health coverage on a risk basis and provides administrative services including claims processing, stop loss insurance and care management. It operates through Health Benefits, CarelonRx pharmacy services, and Carelon Services segments.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Elevance Health Inc stock.
Undervalued: intrinsic value $608.50 per share, market price $430.23, margin of safety 29.3% (as of 2026-10-19).
Discounting its cash flows at 7.8% (average of 3 methods) values the shares at $608.50; the price of $430.23 is 29% below that value, and 80% of that value comes from beyond year five.
Leak Score: 64/100 on 12 of 12 signals (Faint Leak).
17 more funds hold it; the full list is part of the paid plan.
All 11 Healthcare Plans stocks
ELV is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 7.8% (average of 3 methods) values the shares at $608.50; the price of $430.23 is 29% below that value, and 80% of that value comes from beyond year five.
$608.50 per share (as of the 2026-10-19 close), against a market price of $430.23. That is a margin of safety of 29.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for less growth than the company has already delivered. Repeating its past would be enough. Yearly sales growth the price needs: 2.0%. Yearly sales growth it has sustained: 12.5%.
64 out of 100, which we rate "Faint Leak", on 12 of 12 value investing signals.